BNY Mellon Survey: "Significant Gaps" in Managing and Mitigating Counterparty Credit Risk

Forthcoming regulatory changes focused on the standardization of OTC derivatives and the migration to central clearing are leaving buy-side institutions struggling to adapt, according to a BNY Mellon survey of institutional investors published today.

The survey, carried out during the latter part of 2010, establishes how institutions are addressing the challenges of counterparty credit risk and collateral management for OTC derivatives.

According to the report, substantial investment will be

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here:

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: